Verona Pharma PLC ADR (VRNA) — Financial Flexibility Index
Verona Pharma PLC ADR (VRNA) has a Financial Flexibility Index of 0.10x as of June 2025. Free cash flow of $30.56 Million (operating CF $30.56 Million minus capex $0.00) represents 0% of total liabilities ($294.60 Million). Check Verona Pharma PLC ADR investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Verona Pharma PLC ADR Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for Verona Pharma PLC ADR across 20 annual periods. For the full cash flow conversion analysis, see Verona Pharma PLC ADR cash flow conversion.
Annual Financial Flexibility Index for Verona Pharma PLC ADR (2005–2024)
Year-by-year free cash flow to debt coverage for Verona Pharma PLC ADR. Explore VRNA operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.45x | $-121.62 Million | $-122.20 Million | $269.68 Million | ▲ +47.2% |
| 2023 | -0.85x | $-50.22 Million | $-50.22 Million | $58.84 Million | ▲ +58.6% |
| 2022 | -2.06x | $-59.83 Million | $-59.86 Million | $29.00 Million | ▼ -139.4% |
| 2021 | -0.86x | $-33.24 Million | $-33.25 Million | $38.58 Million | ▲ +62.9% |
| 2020 | -2.33x | $-44.99 Million | $-45.08 Million | $19.35 Million | ▲ +21.9% |
| 2019 | -2.98x | $-43.97 Million | $-44.34 Million | $14.78 Million | ▼ -88.9% |
| 2018 | -1.58x | $-22.64 Million | $-22.98 Million | $14.37 Million | ▲ +26.0% |
| 2017 | -2.13x | $-27.68 Million | $-27.97 Million | $13.00 Million | ▼ -355.0% |
| 2016 | -0.47x | $-6.74 Million | $-6.89 Million | $14.40 Million | ▲ +86.3% |
| 2015 | -3.43x | $-9.20 Million | $-9.41 Million | $2.69 Million | ▲ +45.9% |
| 2014 | -6.33x | $-5.17 Million | $-5.51 Million | $816.08K | ▼ -59.1% |
| 2013 | -3.98x | $-3.21 Million | $-3.39 Million | $806.89K | ▲ +67.6% |
| 2012 | -12.30x | $-3.96 Million | $-4.08 Million | $322.11K | ▼ -24.1% |
| 2011 | -9.91x | $-2.40 Million | $-2.44 Million | $242.21K | ▼ -26.7% |
| 2010 | -7.82x | $-2.49 Million | $-2.56 Million | $317.94K | ▼ -40.7% |
| 2009 | -5.56x | $-2.58 Million | $-2.62 Million | $464.08K | ▲ +64.8% |
| 2008 | -15.81x | $-1.94 Million | $-1.98 Million | $123.01K | ▼ -108.9% |
| 2007 | -7.57x | $-2.36 Million | $-2.39 Million | $311.35K | ▼ -48.6% |
| 2006 | -5.09x | $-658.29K | $-687.68K | $129.31K | ▼ -3154.5% |
| 2005 | 0.17x | $3.44K | $3.44K | $20.65K | — |